Skip to main content

Table 2 Market shares and their CAGRs, for the eight countries, from 2010 to 2017

From: An analysis of orphan medicine expenditure in Europe: is it sustainable?

 Market share (%)
ValueVolume
 20102017CAGR20102017CAGR
Orphan3.17.213< 0.1< 0.111
Non-Orphan Branded62.457.3-127.622.6-3
Unbranded28.230.0152.458.11
Other Expendituresa6.35.5-220.019.3-1
  1. aOther expenditures include over-the-counter (OTC) products and vaccines, which have been omitted from this analysis